↓ Skip to main content

Dove Medical Press

Article Metrics

Montelukast: The New Therapeutic Option for the Treatment of Epilepsy

Overview of attention for article published in Journal of experimental pharmacology, January 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters

Readers on

mendeley
2 Mendeley
Title
Montelukast: The New Therapeutic Option for the Treatment of Epilepsy
Published in
Journal of experimental pharmacology, January 2021
DOI 10.2147/jep.s277720
Pubmed ID
Authors

Bekalu Amare Tesfaye, Haftom Gebregergs Hailu, Kaleab Alemayehu Zewdie, Muluken Altaye Ayza, Derbew Fikadu Berhe

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 2 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 1 50%
Librarian 1 50%
Readers by discipline Count As %
Social Sciences 1 50%
Medicine and Dentistry 1 50%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 January 2021.
All research outputs
#11,047,790
of 17,094,905 outputs
Outputs from Journal of experimental pharmacology
#34
of 73 outputs
Outputs of similar age
#150,116
of 250,688 outputs
Outputs of similar age from Journal of experimental pharmacology
#1
of 1 outputs
Altmetric has tracked 17,094,905 research outputs across all sources so far. This one is in the 23rd percentile – i.e., 23% of other outputs scored the same or lower than it.
So far Altmetric has tracked 73 research outputs from this source. They receive a mean Attention Score of 3.6. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,688 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them